XML 111 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
Collaborations - AstraZeneca PLC (Details) - AstraZeneca PLC - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Research and development      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Development costs due to collaboration partner $ 77 $ 74 $ 49
Selling, general and administrative      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cost recoveries 73 60 $ 39
Cost of sales      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Profit and loss share of expenses $ 310 $ 119